Publication: 3101

Publication: 3101

Ratify (Alliance 10603): Prognostic Impact of FLT3 Tyrosine Kinase Domain (TKD) and NPM1 Mutation Status in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Treated with Midostaurin Plus Standard Chemotherapy

DOI

URL

Google Scholar

Citation:: HemaSphere vol 3 (suppl 1) 79-80

Meeting Instance:: EHA 2019
Year:: 2019
Type:: Abstract
Sub type:: Poster Discussion
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 3327

Program:: OGC
Primary Committee:: Leukemia
Sec. Committees:

Pharmas:: Novartis
Grants:: U10CA180821, U10CA180882, U24CA196171

Corr. Author:
Authors:: Maria Teresa Voso Richard A. Larson Thomas W Prior Guido Marcucci Dan Jones Jürgen Krauter Michael Heuser Serena Lavorgna Josep Nomdedeu Susan M. Geyer Rebecca B. Klisovic Andrew Wei Jorge Sierra Miguel A. Sanz Joseph M. Brandwein T. M. M de Witte Joop H. Jansen Dietger Niederwieser Frederick R. Appelbaum Bruno C Medeiros Martin S. Tallman Richard F. Schlenk Arnold Ganser Sergio Amadori Yuan Cheng YinMiao Chen Eva Tiecke Christian Thiede Konstanze Döhner Hartmut Döhner Richard M. Stone Clara D. Bloomfield Francesco Lo-Coco.

Networks:: CA043, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-OH007

Study: CALGB-10603
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: